Indication
moderate to severe Thyroid Eye Disease (TED)
Medicine details
- Medicine name:
- teprotumumab (Tepezza)
- SMC ID:
- SMC2976
- Pharmaceutical company
- Amgen Ltd
- BNF chapter
- Eye
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC